Results 81 to 90 of about 59,572 (271)
Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen +7 more
wiley +1 more source
New Perspectives in the Treatment of Schizophrenia
My thesis explores new approaches and targets regarding Schizophrenia treatment, albeit none are completely approved. Such targets include phosphodiesterase 10A, α7 Nicotinic Receptors, Histamine 3 Receptors, 5-HT6 Receptors, and the cholinergic system ...
Ellaboudy, Omar Fathi
core
The treatment of resistant schizophrenia [PDF]
Department of Psychiatry, Narcology and Medical Psychology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26 ...
Putină, Cristina
core
BackgroundThis study aimed to conduct a systematic review and meta-analysis on cognitive performances of patients with treatment-resistant schizophrenia (TRS) after clozapine treatment and to examine the potential effect of follow-up duration and ...
Sherry Kit Wa Chan +13 more
core +1 more source
ABSTRACT Objective For decades, a persistent claim has been that autobiographical memory loss after electroconvulsive therapy (ECT) for depression might actually contribute to ECT efficacy by reducing or even eliminating autobiographical memories. To test this claim, the primary aim of this study is to examine the association between autobiographical ...
Mike van Kessel +8 more
wiley +1 more source
Schizophrenia is a severe and common psychiatric disease with a lifetime prevalence of 0.5% to 1% globally. Because of limitations of the experimental approach in humans, valid animal models are essential in the effort to identify novel therapeutics for ...
Akihiro Mouri +3 more
doaj +1 more source
Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication:an exploratory trial [PDF]
Background. Although antipsychotic medication is the first line of treatment for schizophrenia, many service users choose to refuse or discontinue their harmacological treatment.
Hutton, P. +49 more
core +1 more source
Protocol: Treatment-resistant schizophrenia criteria.
Treatment-resistant schizophrenia, also known as refractory schizophrenia, is a severe and debilitating form of chronic psychotic disorder. It is characterized by persistent and disabling symptoms such as hallucinations, delusions, thought disorders, and
Josselyn Anjhela Bravo (16711632)
core +1 more source
ABSTRACT Introduction Diabetes, obesity and bipolar disorder often co‐occur and may have shared pathophysiology. Glucagon‐like peptide 1 receptor agonists (GLP‐1RA) treat diabetes and obesity but their impact on bipolar disorder is unknown. In this era of stagnated pharmacotherapy, we examined psychiatric hospitalisation and absence from work due to ...
Heidi Taipale +5 more
wiley +1 more source
The role of the host—Neutrophil biology
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple +4 more
wiley +1 more source

